Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1984
Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist
F Massara, E Ghigo, S Goffi, et al.
Lancet (London, England)
|
August 4, 1979
Biochemical diagnosis of prolactinoma
E E Müller, A Genazzani, F Camanni, et al.
Journal of Endocrinological Investigation
|
April 1, 1980
Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics
M Trovati, F Massara, F Camanni, et al.
Acta Endocrinologica
|
October 1, 1980
Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia
F Massara, F Camanni, L Belforte, et al.
Journal of Endocrinological Investigation
|
April 1, 1987
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia
E Ciccarelli, E Ghigo, E Mazza, et al.
Journal of Endocrinological Investigation
|
February 1, 1987
Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia
E Ciccarelli, E Mazza, E Ghigo, et al.
Acta Endocrinologica
|
July 1, 1983
Effects of naloxone on the insulin and GH responses to alpha-adrenergic stimulation with clonidine
F Massara, P Limone, E Cagliero, et al.
Clinical Endocrinology
|
December 1, 1987
Growth hormone responses to pyridostigmine in normal adults and in normal and short children
E Ghigo, E Mazza, E Imperiale, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1987
Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes
V Martina, M Tagliabue, M Maccario, et al.
Acta Endocrinologica
|
September 1, 1986
Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man
F Massara, E Ghigo, P Molinatti, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1984
Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist
F Massara, E Ghigo, S Goffi, et al.
Lancet (London, England)
|
August 4, 1979
Biochemical diagnosis of prolactinoma
E E Müller, A Genazzani, F Camanni, et al.
Journal of Endocrinological Investigation
|
April 1, 1980
Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics
M Trovati, F Massara, F Camanni, et al.
Acta Endocrinologica
|
October 1, 1980
Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia
F Massara, F Camanni, L Belforte, et al.
Journal of Endocrinological Investigation
|
April 1, 1987
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia
E Ciccarelli, E Ghigo, E Mazza, et al.
Journal of Endocrinological Investigation
|
February 1, 1987
Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia
E Ciccarelli, E Mazza, E Ghigo, et al.
Acta Endocrinologica
|
July 1, 1983
Effects of naloxone on the insulin and GH responses to alpha-adrenergic stimulation with clonidine
F Massara, P Limone, E Cagliero, et al.
Clinical Endocrinology
|
December 1, 1987
Growth hormone responses to pyridostigmine in normal adults and in normal and short children
E Ghigo, E Mazza, E Imperiale, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1987
Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes
V Martina, M Tagliabue, M Maccario, et al.
Acta Endocrinologica
|
September 1, 1986
Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man
F Massara, E Ghigo, P Molinatti, et al.
Page
of 9